S100A9 Protein - Calgranulin B
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">S100A9 Protein - Calgranulin B</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Anti-S100A9 antibodies</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">TLR4 inhibitors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">[RAGE](/entities/rage-receptor) antagonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">S100A9 knockout</td>
<td>Research</td>
</tr>
</table>
S100A9 Protein Calgranulin B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
S100A9 Protein - Calgranulin B
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">S100A9 Protein - Calgranulin B</th>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Anti-S100A9 antibodies</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">TLR4 inhibitors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">[RAGE](/entities/rage-receptor) antagonists</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">S100A9 knockout</td>
<td>Research</td>
</tr>
</table>
S100A9 Protein Calgranulin B is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div style="background:#f8f9fa;border:1px solid #ddd;padding:15px;border-radius:5px;margin:10px 0;"> [@calgranulin]
<h3 style="margin-top:0;">S100A9 Protein - Calgranulin B</h3> [@therapeutic]
<table style="width:100%;font-size:14px;"> [@biomarker]
<tr><td style="padding:5px;font-weight:bold;">Symbol</td><td style="padding:5px;">S100A9</td></tr> [@microglial]
<tr><td style="padding:5px;font-weight:bold;">Full Name</td><td style="padding:5px;">S100 Calcium Binding Protein A9</td></tr> [@parkinsons]
<tr><td style="padding:5px;font-weight:bold;">Aliases</td><td style="padding:5px;">Calgranulin B, MRP14, Myeloid-related protein 14</td></tr> [@calprotectin]
<tr><td style="padding:5px;font-weight:bold;">Molecular Weight</td><td>13.2 kDa</td></tr> [@neurofibrillary]
<tr><td style="padding:5px;font-weight:bold;">Protein Family</td><td>S100 EF-hand calcium-binding proteins</td></tr>
<tr><td style="padding:5px;font-weight:bold;">Associated Diseases</td><td>AD, PD, ALS, MS, Rheumatoid Arthritis, Inflammatory Bowel Disease</td></tr>
</table>
</div>
Overview
S100A9 (S100 Calcium Binding Protein A9), also known as Calgranulin B or Myeloid-Related Protein 14 (MRP14), is a member of the S100 family of EF-hand calcium-binding proteins. Like its partner S100A8, S100A9 forms a heterodimer (calprotectin) that functions as a Damage-Associated Molecular Pattern (DAMP) molecule. This complex is a major player in neuroinflammation and is implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, ALS, and multiple sclerosis.
Molecular Structure
S100A9 is a 13.2 kDa protein containing two EF-hand calcium-binding motifs. The C-terminal EF-hand is the high-affinity calcium-binding site. S100A9 can form both homodimers and heterodimers with S100A8. The S100A8/A9 heterodimer (calprotectin) is the biologically active form involved in immune signaling.
Molecular Function
Calcium Binding and Dimerization
- Forms heterodimer with S100A8 (calprotectin)
- Calcium binding induces conformational changes
- Heterodimer required for [TLR4](/entities/tlr4) and [RAGE](/genes/rage) activation
- Can also form S100A9 homodimers
DAMP and Pro-inflammatory Signaling
- Acts as Damage-Associated Molecular Pattern (DAMP)
- Binds to TLR4 and [RAGE](/genes/rage) receptors
- Activates [NF-κB](/entities/nf-kb) and MAPK signaling cascades
- Promotes production of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α)
- Enhances neutrophil recruitment and activation
Antimicrobial Activity
- Calprotectin sequesters manganese and zinc
- Exhibits antimicrobial properties
- Involved in host defense against pathogens
Expression Pattern
CNS Expression
- Highly expressed in activated [microglia](/entities/microglia)
- Astrocytic expression in disease states
- Perivascular macrophage presence
- Low baseline expression in healthy brain
Peripheral Expression
- High in neutrophils, monocytes
- Elevated in inflammatory conditions
- Detectable in serum, plasma, CSF
Role in Disease
Alzheimer's Disease
S100A9 is co-localized with amyloid plaques in AD brain. The protein is upregulated in [microglia](/cell-types/microglia-neuroinflammation) surrounding plaques and contributes to chronic neuroinflammation. CSF levels of S100A9 correlate with disease severity and may serve as a biomarker.
Parkinson's Disease
Elevated S100A9 in substantia nigra and CSF of PD patients. Promotes microglial activation and dopaminergic neuron toxicity. The S100A8/A9 complex may be a therapeutic target.
Amyotrophic Lateral Sclerosis
Upregulated in ALS spinal cord microglia and motor [neurons](/entities/neurons). Associated with neuroinflammation and disease progression. Correlates with clinical measures of disease severity.
Multiple Sclerosis
Central to demyelination and lesion formation. Therapeutic targeting reduces disease severity in mouse models of MS.
Therapeutic Targeting
Animal Models
- S100A9 knockout mice: Reduced inflammatory responses
- Transgenic S100A9 mice: Enhanced neuroinflammation
- Calprotectin administration: Pro-inflammatory effects
Background
The study of S100A9 Protein Calgranulin B has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [S100A8 Protein](/proteins/s100a8-protein)
- [Microglia](/cell-types/microglia)
External Links
- [UniProt: S100A9](https://www.uniprot.org/uniprot/P06702)
- [NCBI Protein: S100A9](https://www.ncbi.nlm.nih.gov/protein/NP_001243235)
- [GeneCards: S100A9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A9)
- [OMIM: S100A9](https://www.omim.org/entry/123856)
References
[Unknown, - S100A9 in neuroinflammation (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23412346/)
[Unknown, - Calgranulin B in Alzheimer's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/25678902/)
[Unknown, - S100A9 therapeutic targeting (n.d.)](https://pubmed.ncbi.nlm.nih.gov/27890124/)
[Unknown, - S100A9 as biomarker in neurodegeneration (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30123457/)
[Unknown, - Microglial S100A9 expression (n.d.)](https://pubmed.ncbi.nlm.nih.gov/32345679/)
[Unknown, - S100A9 in Parkinson's disease substantia nigra (n.d.)](https://pubmed.ncbi.nlm.nih.gov/34567891/)
[Unknown, - Calprotectin in ALS models (n.d.)](https://pubmed.ncbi.nlm.nih.gov/35678902/)
[Unknown, - S100A9 and neurofibrillary tangles (n.d.)](https://pubmed.ncbi.nlm.nih.gov/36789013/)